Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
My guess is that if you are reading this post, you have been diagnosed with multiple myeloma and your oncologist is urging you to have a stem cell transplant immediately following your induction chemotherapy.
But you are wondering if it is better to transplant or not to transplant? And if you can harvest your stem cells and then wait?
An Autologous Stem Cell Transplant (ASCT) can be a tempting therapy option. Your oncologist tells you that an ASCT is the “best option.” You feel as though it might be best to get it over with. Sure, an ASCT will be tough but then I will be in remission for years…
I know the feeling. I had an ASCT shortly after I was diagnosed with MM. My partial remission lasted for 10 months. I had more therapy and another short remission.
So how am I writing this blog post? I am a long-term MM survivor and MM cancer coach. As the article linked below discusses, MM is a complicated blood cancer. Even MM specialists disagree on the “best option” for MMers.
As MM specialists go, Dr. Berenson is one of the best. He has the best average survival statistics of any MM specialist that I know of. While the long and growing list of FDA approved MM therapies should give MMer’s hope for their long-term survival, I have remained in complete remission since 1999 by living an evidence-based, non-toxic, anti-MM lifestyle.
I believe that the newly diagnosed MMer’s “best option” will be able to manage their MM with the best of both conventional and non-conventional MM therapies.
Whether you are debating treatment options, currently undergoing treatment and experiencing painful side effects, or trying to figure out how to stay in remission, I want to share what I’ve learned from 22 years of full remission from Multiple Myeloma.
Learn about what integrative therapies are and how you can use them to optimize the efficacy of your specific chemotherapy while healing short term and long term side effects.
If you have a question or comment about MM scroll down the page, write a post and I will reply to you ASAP.
“There is a profound disagreement over whether early stem cell transplant (SCT) should still be characterized as a standard early intervention for multiple myeloma (MM), even in relatively young patients…
“The treatment of multiple myeloma is no longer a 100-yard dash; it is a marathon,” According to Dr. Berenson, better-tolerated, newer drug therapies now produce response rates that rival those produced with SCT, while preserving future options when the cancer progresses…
“Patients need to be able to avail themselves of the opportunity to seek the newer therapies. Reducing that ability with too much prior treatment at too high of a dose is detrimental to their long-term outcomes, which not only includes their overall survival but their quality of life,” Dr. Berenson said…
After nearly 3 decades of debate and several randomized phase 3 trials, it is clear that ASCT as a treatment modality has stood the test of time. It continues to be an effective modality to provide durable disease control for myeloma even with the introduction of novel agents.
Given the depth of response and the PFS advantage seen in phase 3 trials, ASCT should be considered as part of the initial therapy.
However, without a clear OS advantage to early ASCT based on the data available today, a delayed ASCT is a reasonable approach should the patient and the treating physician desire to pursue that approach after a thorough discussion of the pros and cons of either approach, as discussed in this article…”